69 related articles for article (PubMed ID: 10952483)
1. Hydroquinine pharmacokinetics after oral administration in adult patients with muscle cramps.
van Kan HJ; Jansen PH; Tuinte C; Smits P; Verbeek AL
Eur J Clin Pharmacol; 2000 Jun; 56(3):263-7. PubMed ID: 10952483
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial of hydroquinine in muscle cramps.
Jansen PH; Veenhuizen KC; Wesseling AI; de Boo T; Verbeek AL
Lancet; 1997 Feb; 349(9051):528-32. PubMed ID: 9048790
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration.
Jansen PH; Veenhuizen KC; Verbeek AL; Straatman H
J Neurol Sci; 1994 Apr; 122(2):157-61. PubMed ID: 8021700
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects.
Khosravan R; Grabowski BA; Wu JT; Joseph-Ridge N; Vernillet L
Clin Pharmacokinet; 2006; 45(8):821-41. PubMed ID: 16884320
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease.
Bramer SL; Forbes WP; Mallikaarjun S
Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man. A study using a stable isotope techique.
Heikkinen H; Saraheimo M; Antila S; Ottoila P; Pentikäinen PJ
Eur J Clin Pharmacol; 2001; 56(11):821-6. PubMed ID: 11294372
[TBL] [Abstract][Full Text] [Related]
8. Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study.
van Heeswijk RP; Veldkamp AI; Mulder JW; Meenhorst PL; Lange JM; Beijnen JH; Hoetelmans RM
AIDS; 2000 Jun; 14(9):F103-10. PubMed ID: 10894270
[TBL] [Abstract][Full Text] [Related]
9. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of proxyphylline in adults after intravenous and oral administration.
Selvig K
Eur J Clin Pharmacol; 1981 Jan; 19(2):149-55. PubMed ID: 7202475
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Study of Intravenous Acetaminophen Administered to Critically Ill Multiple-Trauma Patients at the Usual Dosage and a New Proposal for Administration.
Fuster-Lluch O; Zapater-Hernández P; Gerónimo-Pardo M
J Clin Pharmacol; 2017 Oct; 57(10):1345-1352. PubMed ID: 28419483
[TBL] [Abstract][Full Text] [Related]
12. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic Properties and Tolerability of Cycloserine Following Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose 3-Way Crossover Study.
Zhou H; Wu G; Hu X; Zhu M; Zhai Y; Liu J; Shentu J; Wu L
Clin Ther; 2015 Jun; 37(6):1292-300. PubMed ID: 25869627
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic profile of intramuscular fulvestrant in advanced breast cancer.
Robertson JF; Erikstein B; Osborne KC; Pippen J; Come SE; Parker LM; Gertler S; Harrison MP; Clarke DA
Clin Pharmacokinet; 2004; 43(8):529-38. PubMed ID: 15170367
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
[TBL] [Abstract][Full Text] [Related]
16. Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers.
Lima DR; Santos RM; Werneck E; Andrade GN
Eur J Drug Metab Pharmacokinet; 1991; 16(3):161-70. PubMed ID: 1814733
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration.
Stass H; Kubitza D; Schühly U
Clin Pharmacokinet; 2001; 40 Suppl 1():1-9. PubMed ID: 11352436
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers.
Cass LM; Efthymiopoulos C; Bye A
Clin Pharmacokinet; 1999; 36 Suppl 1():1-11. PubMed ID: 10429835
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
Endrikat J; Blode H; Gerlinger C; Rosenbaum P; Kuhnz W
Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
